Industrial grants | Danish Diabetes and Endocrine Academy
|
  • Search form

Industrial grants

● Industrial PhD Scholarships 2021 / 2020 / 2019
● Industrial Postdoctoral Fellowships 2021

● Industrial Postdoctoral Fellowships 2019

Industrial PhD Scholarships

2021

MSc Nynne Holdt-Caspersen

Aalborg University, Faculty of Medicine

Co-funding company: Novo Nordisk A/S 

Continuous glucose monitoring to support people on oral antidiabetic treatment

Read the Danish profile

Read the English profile

2020

MSc Mathias Bonde Møllerhøj

University of Copenhagen, Health Sciences

Co-funding company: Gubra

Identification and validation of fibrosis targets in non-alcoholic steatohepatitis

2019

MSc Flora Alexopoulou

University of Copenhagen, Health Sciences

Co-funding company: Gubra

Array-assisted Peptide Drug Discovery for Obesity and Cancer Cachexia

   

MSc Sarina Gadgaard

University of Copenhagen, Health Sciences

Co-funding company: Bainan Biotech

Treating diabetes induced osteoporosis using a new GIP/GLP-2 dual agonist 

   

MSc Sofia Wareham Mathiassen

University of Copenhagen, Health Sciences 

Co-funding company: Novo Nordisk A/S

Assessment, mapping, and benchmark of antimicrobial technologies for future injection device application 

Read the English profile

   

MSc Christine Bodelund Christiansen

Aarhus University, Health Sciences

Co-funding company: Elkærholm

 

Aronia As A Part of The Type 2 Diabetes Treatment Regimen 

Read the English profile



Industrial Postdoctoral Fellowships

2021

MSc, PhD Jens Frey Halling

University of Copenhagen, Department of Biology

Co-funding company: Novo Nordisk A/S

Regulation of mitochondrial energy expenditure in obesity

Read the Danish profile

Read the English profile

 

MSc, PhD Rikke Linnemann Nielsen

Novo Nordisk A/S

Co-funding company: Novo Nordisk A/S

Target discovery using machine learning approaches in cardiometabolic disease

Read the Danish profile

Read the English profile

2019

PhD, MSc Charlotte Bayer Christiansen

University of Copenhagen, Health Sciences

Co-funding company: Bainan Biotech

Investigating a potential future treatment strategy for diabetes-induced osteoporosis